NFKB1 and gastric cancer: Jiang et al. reported that ADAMTS19 expression was decreased in gastric cancer, that it inhibited gastric cancer cell migration and invasion by targeting S100A16 through the NF-κB pathway, and that ADAMTS19 was a potential metastatic and survival biomarker for gastric cancer30.